LINC00921: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC00921

NCBI ID: G283876

LINC00921

Other Name(s): Long intergenic non-protein coding RNA 921 | long intergenic non-protein coding RNA 921

LINC00921: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Introduction

LINC00921 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a unique structure that consists of 1,222 exons, and its primary function is not well understood. However, research has shown that LINC00921 is involved in various cellular processes, including cell adhesion, migration, and invasion.

Drug Targeting

LINC00921 is a potential drug target due to its unique structure and its involvement in cellular processes that are crucial for human diseases. One of the potential drug targets for LINC00921 is cancer. Cancer is a leading cause of death worldwide, and there is a significant need for new treatments that can effectively target this disease.

LINC00921 has been shown to be involved in various cellular processes that are crucial for cancer cell growth and progression. For instance, LINC00921 has been shown to be involved in the regulation of cell adhesion, which is a critical process for cancer cell survival.

Another potential drug target for LINC00921 is neurodegenerative diseases, such as Alzheimer's disease. LINC00921 has been shown to be involved in the regulation of a protein called synaptophysin, which is essential for the structure and function of neurons.

Biomarker

LINC00921 may also be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and genetic disorders. Since LINC00921 is involved in various cellular processes, it may be used as a biomarker for diseases that are characterized by disruptions in these processes.

Conclusion

In conclusion, LINC00921 is a long intergenic non-protein-coding RNA that has unique structure and is involved in various cellular processes. Its potential as a drug target or biomarker makes it an attractive target for researchers to study. Further studies are needed to fully understand the role of LINC00921 in various cellular processes and to determine its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 921

The "LINC00921 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00921 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets